REQUEST A DEMO
Total
USD $0.00
Search more companies

Teva Czech Industries s.r.o. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Teva Czech Industries s.r.o. Profile Updated: August 29, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Teva Czech Industries s.r.o., formerly known as Galena, is a major pharmaceutical manufacturer. Headquartered in Israel, the company has 74 production sites in three dozen countries. Teva operates a manufacturing facility in Opava, where it has 2 divisions: TAPI Division and PHARMA Division. The Prague Commercial Unit has 3 Business Units: Generics, Specialty and OTC.

Headquarters
Komarov, Ostravska 305/29
Opava; Moravskoslezsky; Postal Code: 74770

Contact Details: Purchase the Teva Czech Industries s.r.o. report to view the information.

Website: http://www.tevapharm.cz/

Basic Information
Total Employees:
Purchase the Teva Czech Industries s.r.o. report to view the information.
Outstanding Shares:
Purchase the Teva Czech Industries s.r.o. report to view the information.
Registered Capital:
Purchase the Teva Czech Industries s.r.o. report to view the information.
Financial Auditors:
Purchase the Teva Czech Industries s.r.o. report to view the information.
Ratings:
Purchase the Teva Czech Industries s.r.o. report to view the information.
Incorporation Date:
December 31, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Company Performance
Financial values in the chart are available after Teva Czech Industries s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
14.01%
Total operating revenue
13.74%
Operating profit (EBIT)
88.37%
EBITDA
68.58%
Net Profit (Loss) for the Period
70.24%
Total assets
-23.52%
Total equity
-27.48%
Operating Profit Margin (ROS)
11.04%
Net Profit Margin
8.98%
Return on Equity (ROE)
13.03%
Quick Ratio
-1.9%
Cash Ratio
0%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?